Clinical Trial Update: Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With Degarelix [Phase 4]

View source ↗

Summary

Phase IV clinical trial evaluating bone mineral density in men with non-bone-metastatic prostate cancer treated with degarelix.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Firmagon (Degarelix)

Snippet

Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Conditions: Prostate Cancer | Phase 4 | Status: UNKNOWN